Literature DB >> 19578410

Treatment of depressive disorders.

Tom Bschor, Mazda Adli.   

Abstract

INTRODUCTION: A confusing variety of options are available for the treatment of depressive disorders.
METHOD: Selective literature review under consideration of current guidelines.
RESULTS: The treatment of depression can be divided into acute, maintenance and prophylactic phases. The basic forms of treatment are pharmacotherapy, psychotherapy, and supportive strategies. The approximately 30 antidepressants currently on the market differ mainly with respect to their side effect profiles. Of the specific types of psychotherapy, cognitive behavioral therapy, psychodynamic therapy, and psychoanalysis are funded by the statutory health insurance providers in Germany. All treatment strategies (except for sleep deprivation) show a latency of onset of several weeks and a nonresponse rate of about 30% to 50%. In clinical practice it is essential to follow a stepwise procedure and to perform a standardized evaluation of response after the latency period. In the event of nonresponse, the next step of treatment should be initiated. DISCUSSION: Depressive disorders have a good prognosis provided one takes best advantage of the available treatment options. Preconditions are continuation of treatment for an appropriate length of time (for antidepressants ca. 4 to 6 weeks, for psychotherapy ca. 4 to 12 weeks) and standardized evaluation of response thereafter.

Entities:  

Keywords:  antidepressants; depression; psychotherapy; stepwise antidepressant treatment; treatment algorithm

Year:  2008        PMID: 19578410      PMCID: PMC2697009          DOI: 10.3238/arztebl.2008.0782

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  20 in total

1.  Affective disorders and suicide risk: a reexamination.

Authors:  J M Bostwick; V S Pankratz
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  A meta-analysis of the efficacy of cognitive therapy for depression.

Authors:  K S Dobson
Journal:  J Consult Clin Psychol       Date:  1989-06

Review 4.  Management of recurrent depression.

Authors:  D J Kupfer
Journal:  J Clin Psychiatry       Date:  1993-02       Impact factor: 4.384

5.  Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons.

Authors:  R J DeRubeis; L A Gelfand; T Z Tang; A D Simons
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

6.  Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach.

Authors:  F Leichsenring
Journal:  Clin Psychol Rev       Date:  2001-04

7.  The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials.

Authors:  D A Lawlor; S W Hopker
Journal:  BMJ       Date:  2001-03-31

Review 8.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

9.  The efficacy of brief dynamic psychotherapy: a meta-analysis.

Authors:  P Crits-Christoph
Journal:  Am J Psychiatry       Date:  1992-02       Impact factor: 18.112

10.  Researcher allegiance and meta-analysis: the case of cognitive therapy for depression.

Authors:  E A Gaffan; I Tsaousis; S M Kemp-Wheeler
Journal:  J Consult Clin Psychol       Date:  1995-12
View more
  14 in total

1.  Literature is subject to publication bias.

Authors:  Henning Schauenburg
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

2.  Stable therapeutic effects thanks to psychodynamic therapy.

Authors:  Falk Leichsenring
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

3.  The value of psychotherapeutic methods in treating depression.

Authors:  Volker Waldmann
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

4.  Some additional points.

Authors:  Bruno Müller-Oerlinghausen
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

5.  Opipramol as nighttime medication.

Authors:  Ulrich Leutgeb
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

6.  Misleading statements.

Authors:  Volker Schulz
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

Review 7.  The role of extended reality technology in healthcare education: Towards a learner-centred approach.

Authors:  Abison Logeswaran; Chris Munsch; Yu Jeat Chong; Neil Ralph; Jo McCrossnan
Journal:  Future Healthc J       Date:  2021-03

8.  Pirlindole in the treatment of depression: a meta-analysis.

Authors:  Ana Macedo; Eva Leiria; Augusto Filipe
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 9.  Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients.

Authors:  Jonathan Henssler; Tom Bschor; Christopher Baethge
Journal:  Can J Psychiatry       Date:  2016-01-01       Impact factor: 4.356

Review 10.  Chronic and treatment resistant depression: diagnosis and stepwise therapy.

Authors:  Tom Bschor; Michael Bauer; Mazda Adli
Journal:  Dtsch Arztebl Int       Date:  2014-11-07       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.